Renal imaging utilising positron emission tomography (PET) has emerged as a powerful method in the evaluation of kidney structure and function. By harnessing radiotracers that target specific renal ...

Stage 2 clear cell renal cell carcinoma is typically curable, especially when detected early. Surgery remains the cornerstone ...

The management of renal cell carcinoma (RCC) has transformed over the past 20 years, and recent advances in diagnostic and therapeutic modalities have the potential to further improve patient outcomes ...

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

U.S.-based researchers examined the burden of imaging in a population of patients with ADPKD, versus that of patients with chronic kidney disease (CKD). People with ADPKD underwent more abdominal ...

In December 2025, we reviewed the recommendations on point-of-care creatinine devices for assessing kidney function before CT imaging with intravenous contrast. Surveillance decision We will not ...

Contrast-induced nephropathy is rare. It results from exposure to contrast dyes during certain imaging tests and cardiology procedures. People living with diabetes or advanced kidney disease may be at ...

Biologically optimised plasma p-tau217 cutoffs improve amyloid beta detection accuracy and cost efficiency. Learn more about ...

Lower kidney function is associated with elevated Alzheimer’s blood biomarkers, raising implications for dementia diagnosis ...

What is kidney cancer? Kidney cancer is a disease where cancer cells begin to develop abnormally in the kidneys. As cancer cells grow rapidly, they can form a tumor, and ...

or on the link below. The management of renal cell carcinoma (RCC) has advanced significantly in the past two decades. Many promising functional imaging modalities such as radiolabeled tracer ...